Carrillo-Garrido A, Romero-Díaz J, Ocampo-Torres MC, Criales-Vera SA

Language: Spanish
References: 12
Page: 109-117
PDF size: 371.91 Kb.

ABSTRACT

Background: The medical literature talks about complications and pulmonary, pleural and mediastinal comorbidity in patients with Systemic Lupus Erythematosus, however, there is no consensus that supports simple chest CT as a screening method for such disease.
Objective: To identify the most common pulmonary, pleural and mediastinal findings and morbidities that may be found in the Mexican population having long standing SLE. To discuss the importance and usefulness of CT scan in these patients.
Material and method: A cross-sectional descriptive study was conducted at the Instituto Nacional de Cardiología Ignacio Chávez from April to June 2017, including patients diagnosed with Systemic Lupus Erythematosus of more than 10 years who had a simple chest CT to assess pulmonary, pleural, cardiovascular and abdominal findings, as well as in bones and soft tissue.
Results: Forty-one patients diagnosed with SLE (›4 ACR criteria) were included, 38 (93%) females and 3 (7%) males. Pulmonary findings were predominant, found in 82% of patients, 17% with nodules. In the cardiovascular system, 43.9% had systemic atherosclerotic disease, of these, 21% had a positive Ca Score, and 17% had pulmonary hypertension. In abdomen, splenic granulomas predominated.
Discussion: Chest CT is useful in patients with SLE for prevention of comorbidities, mainly cardiovascular and pulmonary, since they are more prevalent in the Mexican population.
Conclusion: A chest CT is useful in patients with SLE to prevent comorbidities, mainly cardiovascular and pulmonary, since they are more prevalent in the Mexican population.

REFERENCES

1. Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. RadioGraphics. 2004;24:1069-86.

2. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308-18.

3. Sánchez S, Barajas G, Ramírez E, Moreno A, Barbosa O. Lupus eritematoso: enfermedad autoinmune sistémica y órgano específico. Rev Biomed. 2004;15:173-80.

4. Nucamendi GC, Guillén G, Sánchez EM. Boletín Epidemiológico: Lupus Eritematoso Sistémico. Secretaría de Salud. Departamento de Análisis de Información Epidemiológica. 2013;30:1-4.

5. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3:1-54.

6. Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996;166:301-7.

7. Bankier AA, Kiener HP, Wiesmayr MN, Fleischmann D, Kontrus M, Herold CJ, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology. 1995;196:835-40.

8. Keane MP, Lynch JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax. 2000;55:159-66.

9. Horn CA. Pulmonary hypertension and autoimmune disease. Chest. 1993;104:279-82.

10. Romero-Díaz J, Vargas-Vorackova F, Kimura-Hayama E, Cortázar-Benítez LF, Gijón-Mitre R, Criales S, et al. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford). 2012;51:110-9.

11. Lin K, Lloyd-Jones DM, Li D, Liu Y, Yang J, Markl M, et al. Imaging of cardiovascular complications in patients with systemic lupus erythematosus. Lupus 2015;24):1126-34.

12. Tieng AT, Sadow CA, Hochsztein JG, Putterman C. Diffuse calcifications of the spleen: a novel association with systemic lupus erythematosus. Semin Arthritis Rheum. 2011;41:187-93.